Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer	Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm	Recruiting	Phase 2	2022-10-27		NCT05595590

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tianjin Medical University Cancer Institute and Hospital	287

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sichuan Cancer Hosiptal	Chengdu	China	1
Tianjin Medical University Cancer Institute and Hospital	Tianjin	China	20

Clinical trials